I am a physician-executive with an MD and MBA, bringing more than 11 years of progressive experience across regulatory affairs, medical affairs, and pharmacovigilance. Over the past five years at ClinChoice, I have deliberately expanded my scope across all three pillars of pharma medicine, building a broad and practical understanding of the industry.
I specialize in aggregate safety reporting, benefit-risk evaluation, and audit-ready compliance. I have co-authored PSUR/PBRER reports end-to-end for a multinational consumer-health portfolio and have worked across Health Canada, FDA, EMA, and ICH-GCP frameworks. I am comfortable translating complex clinical and safety data into clear recommendations for executive, KOL, and health-authority stakeholders.
My experience also includes medical affairs leadership, where I have driven evidence-generation projects, built scientific literature databases, and supported product-lifecycle strategy. I have partnered closely with R&D, regulatory, and pharmacovigilance teams to align medical strategy with business and compliance goals.
In regulatory affairs, I have reviewed and approved large volumes of promotional assets, redesigned processes to reduce workload by 30%, and maintained zero regulatory findings across external audits. I also helped architect a claims library with more than 1,600 approved claims, which contributed to recognition through the J&J MedTech Inspire Award.
Alongside my industry work, I remain an actively practicing physician. I have ongoing telehealth experience, have led multidisciplinary clinical teams, and have maintained direct patient care to keep my clinical judgment current. My background includes surgical training and public-health clinical governance work with the Department of Health.
I hold a Global MBA from The University of Western Australia, a Postgraduate Diploma in Business Management from the Asian Institute of Management, a Doctor of Medicine from De La Salle Health Sciences Institute, and a BS in Biochemistry from De La Salle University. I am fluent in English, Mandarin, and Tagalog, and I am based in the Philippines.
Co-author aggregate safety reports (PSUR/PBRER) for Kenvue consumer-health products across the Canadian market; own the end-to-end PV reporting lifecycle; serve as medical point-of-contact for product-safety decisions and benefit-risk evaluation; operate in Argus, ORS, MedDRA, and CEDMS.
Served as medical intelligence hub for Kenvue’s consumer-health portfolio; drove evidence-generation projects; screened and abstracted publications; built and governed a centralized scientific-literature database; partnered with R&D, regulatory, and pharmacovigilance teams.
Reviewed and approved promotional assets against FDA, EMA, and local standards; delivered workload reduction through process redesign and SOPs; supported international claims harmonization and compliance across markets.
Led a multidisciplinary clinical team of specialist physicians; ran monthly clinical case and protocol review meetings; owned clinical-quality governance; sustained high patient satisfaction across teleconsultations; mentored and trained physicians on telehealth best practices.
Provided senior medical and scientific advisory for product development; authored the Pedia-Herbal white paper; represented the medical function at industry conventions.
Performed 100+ minor and major operative procedures with zero postoperative complications; developed frontline clinical decision-making under pressure.
Provided clinical oversight of government hospitals and LGUs across Luzon; contributed to Universal Health Care Act policy.
Global Master of Business Administration
Postgraduate Diploma in Business Management
Doctor of Medicine
Ranked 50/143; Full Academic Scholarship (Years 2-4).
BS Biochemistry
Dean’s List.
This professional hasn’t added portfolio projects yet.
This professional hasn’t listed any services yet.
